To view digital features for this article go to Introduction Type 2 diabetes (T2D) is a progressive, chronic, metabolic disease characterised by persistent hyperglycaemia which, if left untreated, is associated with increased risk of long-term microvascular and macrovascular complications [1]
Emerging research suggests GLP-1 receptor agonists may influence inflammatory pathways, raising questions about their utility in autoimmune conditions such as rheumatoid arthritis
Retatrutide represents the third wave, and understanding how it stacks up against the alternatives helps bodybuilders make informed decisions
You may experience increased appetite, weight regain, changes in blood glucose levels, and return of pre-treatment metabolic conditions
If it cant protect it, then B12 gets damaged, and it cant activate the cells as it should